Adam Levy
2023 - Mineralys Therapeutics
In 2023, Adam Levy earned a total compensation of $2.2M as Chief Financial Officer and Secretary at Mineralys Therapeutics, a 115% increase compared to previous year.
Compensation breakdown
| Bonus | $21,375 |
|---|---|
| Non-Equity Incentive Plan | $171,000 |
| Option Awards | $1,533,806 |
| Salary | $450,000 |
| Other | $13,200 |
| Total | $2,189,381 |
Levy received $1.5M in option awards, accounting for 70% of the total pay in 2023.
Levy also received $21.4K in bonus, $171K in non-equity incentive plan, $450K in salary and $13.2K in other compensation.
Rankings
In 2023, Adam Levy's compensation ranked 474th out of 3,006 executives tracked by ExecPay. In other words, Levy earned more than 84.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 474 out of 3,006 | 84th |
Division Manufacturing | 272 out of 1,650 | 84th |
Major group Chemicals And Allied Products | 187 out of 918 | 80th |
Industry group Drugs | 184 out of 881 | 79th |
Industry Pharmaceutical Preparations | 115 out of 637 | 82nd |
Source: SEC filing on April 9, 2024.
Levy's colleagues
We found two more compensation records of executives who worked with Adam Levy at Mineralys Therapeutics in 2023.